XOLAIR

LIVE

Serial Number

85829727

Owner

Novartis AG

Attorney

Maury M. Tepper, III

First Use Date

Mar 31, 2014

Filing Date

Jan 23, 2013

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

XOLAIR Trademark

Serial Number: 85829727 • Registration: 4918470

XOLAIR is a trademark filed by Novartis AG on January 23, 2013. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Novartis AG (13 trademarks)

CH-4002 Basel

Entity Type: 03

Legal Representation

Attorney of Record

Maury M. Tepper, III

5,827 trademarks filed View all →

Correspondence Address

Maury M. Tepper, III TEPPER & EYSTER, PLLC

3724 Benson Drive

RALEIGH, NC 27609

United States

Trademark Details

Filing Date

January 23, 2013

Registration Date

March 15, 2016

First Use Anywhere

March 31, 2014

First Use in Commerce

March 31, 2014

Published for Opposition

June 4, 2013

Goods & Services

Pharmaceutical preparations for the treatment of urticaria

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Jan 12, 2026 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Jan 12, 2026 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Jan 12, 2026 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 12, 2026 APRE

TEAS SECTION 8 & 9 RECEIVED

Oct 7, 2025 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Mar 15, 2025 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Jul 18, 2022 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jul 18, 2022 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jul 16, 2022 APRE

TEAS SECTION 8 & 15 RECEIVED

Feb 8, 2022 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Mar 15, 2021 REM1

REGISTERED-PRINCIPAL REGISTER

Mar 15, 2016 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Feb 6, 2016 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Feb 5, 2016 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Feb 5, 2016 SUPC

USE AMENDMENT FILED

Jan 28, 2016 IUAF

TEAS STATEMENT OF USE RECEIVED

Jan 28, 2016 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 30, 2015 EXRA

SOU EXTENSION 4 GRANTED

Jul 29, 2015 EX4G

SOU EXTENSION 4 FILED

Jul 24, 2015 EXT4

SOU TEAS EXTENSION RECEIVED

Jul 24, 2015 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 31, 2015 EXRA

SOU EXTENSION 3 GRANTED

Jan 30, 2015 EX3G

SOU EXTENSION 3 FILED

Jan 27, 2015 EXT3

SOU TEAS EXTENSION RECEIVED

Jan 27, 2015 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 26, 2014 EXRA

SOU EXTENSION 2 GRANTED

Aug 25, 2014 EX2G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 20, 2014 AITU

SOU EXTENSION 2 FILED

Jul 27, 2014 EXT2

SOU TEAS EXTENSION RECEIVED

Jul 27, 2014 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 17, 2014 EXRA

SOU EXTENSION 1 GRANTED

Jan 15, 2014 EX1G

SOU EXTENSION 1 FILED

Jan 15, 2014 EXT1

SOU TEAS EXTENSION RECEIVED

Jan 15, 2014 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 30, 2013 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 4, 2013 NPUB

PUBLISHED FOR OPPOSITION

Jun 4, 2013 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 15, 2013 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Apr 26, 2013 CNSA

ASSIGNED TO EXAMINER

Apr 26, 2013 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 29, 2013 NWOS

NEW APPLICATION ENTERED

Jan 26, 2013 NWAP

Related Trademarks

More from this Owner

NOVARTIS RLT NOW

ZENLUMIQA

TIVELGO

Serial #79452602

More in Same Class

EXTRACT ARTIST EA